{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:52:53Z","timestamp":1793407973175,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Womens Health"],"abstract":"Introduction<\/jats:title>This study assessed fertility knowledge in adults with sickle cell disease using the Cardiff Fertility Knowledge Scale and Fertility Treatment Perception Survey and compared knowledge scores in respondents with sickle cell disease to previously reported unaffected cohorts.<\/jats:p><\/jats:sec>Methods<\/jats:title>This cross-sectional study surveyed adults over age 18 with sickle cell disease at an adult sickle cell disease center using a 35-question survey addressing infertility risk factor knowledge and perceptions of fertility treatment. Analyses included summary statistics for continuous and categorical variables, univariate linear regression, and Mann-Whitney U tests for group comparisons of Fertility Knowledge Scale scores. Fertility Treatment Perception Survey scores were measured by medians of the two positive statements and four negative statements to generate separate positive and negative treatment belief scores. Statistical significance was set at p<\/jats:italic>\u2009&lt;\u20090.05 for all analyses.<\/jats:p><\/jats:sec>Results<\/jats:title>Ninety-two respondents (71 female, 21 male) with median age of 32 years (IQR: 25.0, 42.5) completed the survey between October 2020-May 2021. Sixty-five percent of respondents reported taking sickle cell disease treatment and 18% reported refusing at least one sickle cell disease treatment due to fertility concerns. The mean Fertility Knowledge Score was 49% (SD: 5.2), lower than reported in an international cohort (57% vs. 49%, p<\/jats:italic>\u2009=\u20090.001), and higher than in a cohort of reproductive-aged Black women in the USA (49% vs. 38%, p<\/jats:italic>\u2009=\u20090.001). Less than 50% of respondents correctly identified common infertility risk factors including sexually transmitted infections, advanced age, and obesity. Mean positive fertility perception score was 3 (IQR 3, 4), and negative fertility perception score was 3.5 (IQR 3, 4). Factors associated with agreement with negative fertility perception statements included: trying to conceive, refusing sickle cell disease treatment, and undergoing fertility treatment.<\/jats:p><\/jats:sec>Discussion<\/jats:title>Opportunities exist to improve knowledge of infertility risk factors among adults with sickle cell disease. This study raises the possibility that nearly one in five adults with sickle cell disease refuse SCD treatment or cure due to infertility concerns. Education about common infertility risks factors needs to be addressed alongside disease- and treatment- associated fertility risks.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgwh.2023.1191064","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:29:34Z","timestamp":1686205774000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Knowledge of fertility and perception of fertility treatment among adults with sickle cell disease (KNOW FERTILITY)"],"prefix":"10.3389","volume":"4","author":[{"given":"Bria","family":"Carrithers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maidah","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Gemmill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaria C.","family":"Cayton Vaught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy S.","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia H.","family":"Pecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202101190","article-title":"Sickle cell disease","volume":"174","author":"Pecker","year":"2021","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/jcm11092318","article-title":"Fertility after curative therapy for sickle cell disease: a comprehensive review to guide care","volume":"11","author":"Nickel","year":"2022","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"892184","DOI":"10.3389\/fendo.2022.892184","article-title":"Testosterone deficiency in sickle cell disease: recognition and remediation","volume":"13","author":"Musicki","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jtct.2022.08.014","article-title":"Comparison of anti-mullerian hormone levels Pre- and post-hematopoietic cell transplantation in pediatric and adolescent females with sickle cell disease","volume":"28","author":"George","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1182\/blood.2021012756","article-title":"Diminished ovarian reserve in young women with sickle cell anemia","volume":"139","author":"Pecker","year":"2022","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/ajh.26286","article-title":"All ESCORT HU investigators. Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective ESCORT-HU cohort study","volume":"96","author":"de Montalembert","year":"2021","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"00353","DOI":"10.1016\/S2352-3026(22)00353-2","article-title":"Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care","author":"Pecker","year":"2023","journal-title":"Lancet Haematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/bjh.16976","article-title":"Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the multicenter study of hydroxycarbamide","volume":"191","author":"Pecker","year":"2020","journal-title":"Br J Haematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/hematology.2022000381","article-title":"No crystal stair: supporting fertility care and the pursuit of pregnancy in women with sickle cell disease","volume":"2022","author":"Pecker","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/10245332.2018.1430521","article-title":"Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease","volume":"8","author":"Karafin","year":"2018","journal-title":"Hematology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.jsxm.2022.07.013","article-title":"Predictors of sex-induced crisis, sexual function and marital satisfaction in women with sickle cell disease","volume":"11","author":"Adesoye","year":"2022","journal-title":"J Sex Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/hematology.2022000380","article-title":"Epidemiology and treatment of priapism in sickle cell disease","volume":"1","author":"Idris","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e30152","DOI":"10.1002\/pbc.30152","article-title":"Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in medicaid, 2004\u22122019","volume":"70","author":"Tang","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2020006270","article-title":"Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease","volume":"137","author":"Joseph","year":"2021","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcmd.2015.03.012","article-title":"The effects of hydroxyurea and bone marrow transplant on anti-m\u00fcllerian hormone (AMH) levels in females with sickle cell anemia","volume":"55","author":"Elchuri","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bjh.17658","article-title":"Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease","volume":"194","author":"Pecker","year":"2021","journal-title":"Br J Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0178413","DOI":"10.1371\/journal.pone.0178413","article-title":"Proponent or collaborative: physician perspectives and approaches to disease modifying therapies in sickle cell disease","volume":"12","author":"Bakshi","year":"2017","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e28861","DOI":"10.1002\/pbc.28861","article-title":"Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist\/oncologists\u2019 practice focus: a sickle cell transplant advocacy and research alliance (STAR) study","volume":"68","author":"Meier","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/j.bbmt.2020.03.025","article-title":"Fertility concerns and access to care for stem cell transplantation candidates with sickle cell disease","volume":"2","author":"Mishkin","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e27019","DOI":"10.1002\/pbc.27019","article-title":"Fertility perspectives and priorities among male adolescents and young adults in cancer survivorship","volume":"65","author":"Nahata","year":"2018","journal-title":"Pediatr Blood Cance"},{"key":"B23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1182\/hematology.2022000382","article-title":"Incorporating gonadal health counseling into pediatric care of sickle cell patients","author":"Meacham","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/humrep\/des402","article-title":"Fertility knowledge and beliefs about fertility treatment: findings from the international fertility decision-making study","volume":"28","author":"Bunting","year":"2013","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40834-019-0097-x","article-title":"Infertility knowledge and treatment beliefs among African American women in an urban community","volume":"4","author":"Wiltshire","year":"2019","journal-title":"Contracept Reprod Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"key":"B27","year":""},{"key":"B28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.hoc.2022.07.010","article-title":"Go the distance: reproductive health care for people with sickle cell disease","volume":"36","author":"Pecker","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10815-020-01837-z","article-title":"Literacy assessment of preimplantation genetic patient education materials exceed national Reading levels","volume":"8","author":"Early","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10815-021-02358-z","article-title":"Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait","author":"Early","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/pds.4860","article-title":"National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997\u20132017","volume":"9","author":"Su","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpeds.2018.05.019","article-title":"Targeted hydroxyurea education after an emergency department visit increases hydroxyurea use in children with sickle cell Anemia","volume":"201","author":"Pecker","year":"2018","journal-title":"J Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/ehm.10.22","article-title":"Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities","volume":"3","author":"Brandow","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","article-title":"National institutes of health consensus development conference statement: hydroxyurea treatment for sickle cell disease","volume":"12","author":"Brawley","year":"2008","journal-title":"Ann Intern Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/bjh.1767","article-title":"Management of sickle cell disease in pregnancy. A British society for haematology guideline","volume":"194","author":"Oteng-Ntim","year":"2021","journal-title":"Br J Haematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1182\/bloodadvances.202200700","article-title":"Fertility testing knowledge and attitudes in male adolescents and young adults with SCD and their caregivers: a pilot study","volume":"6","author":"Nahata","year":"2022","journal-title":"Blood Adv"},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2023.1191064\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:29:35Z","timestamp":1686205775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2023.1191064\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":37,"alternative-id":["10.3389\/fgwh.2023.1191064"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2023.1191064","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"article-number":"1191064"}}